Date	Period	Revenue/Estimate	Earnings Call
Mar 18, 2024	2024/Q4	0.000 / 698.000M	--
Dec 14, 2023	2024/Q3	0.000 / 523.000M	--
Sep 14, 2023	2024/Q2	0.000 / 349.000M	--
Jun 14, 2023	2024/Q1	0.000 / 174.000M	--
Mar 16, 2023	2023/Q4	0.000 / 875.000M	--

DatePeriodRevenue/EstimateEarnings Call

Mar 18, 20242024/Q40.000 / 698.000M--

Dec 14, 20232024/Q30.000 / 523.000M--

Sep 14, 20232024/Q20.000 / 349.000M--

Jun 14, 20232024/Q10.000 / 174.000M--

Mar 16, 20232023/Q40.000 / 875.000M--

Unlock Free Earnings Estimates

Open Account

SanBio: Financial results briefing materials for the 2nd quarter of the fiscal year ending January 2025

Sep 18 02:00 ET

SanBio: Extraordinary Report

Sep 17 02:02 ET

SanBio: Interim Report - 12th Period (2024/02/01 - 2025/01/31)

Sep 17 02:01 ET

SanBio: Confirmatory letter.

Sep 17 02:01 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Jul 2, 2024

Underper form

No Data